The present invention relates to a portable nebulizer that is easy to use and provides efficient delivery of a medication to a target location.
A nebulizer is often used for delivering medications for treating respiratory diseases. A nebulizer converts a liquid medication into an aerosol, which is inhaled by the user. The deposition of the medication into the target location and the efficacy of drug delivery depend largely on the particle or droplet size and its variability. For example, if the particle size is too large, much of the medication is often deposited in the throat instead of reaching the target location such as the lungs. In addition, conventional nebulizers are often noisy, difficult to operate and large, requiring the use of tubes, face masks, external compressors, etc. These disadvantages often affect patient compliance.
There continues to be a need for nebulizers that are quiet and have improved portability, operability and delivery efficacy.
In one embodiment, the present disclosure provides a portable nebulizer comprising a housing, a mouthpiece, a reservoir, a disk having multiple pores, and a unit that is configured to cause the disk to vibrate, wherein the vibration of the disk creates a pressure differential that causes a fluid from the reservoir to move through the disk to create an aerosol for delivery. In one embodiment, the mouthpiece may be held in place with at least one metal plate imbedded in the mouthpiece and at least one magnet in the housing. In certain embodiments, the reservoir may have a non-cylindrical shape. In certain embodiments, a cross section of the reservoir has a non-circular shape. In one embodiment, the nebulizer may comprise a battery and a USB port for charging the battery. In one embodiment, the nebulizer is portable and spill-proof when the reservoir is filled with a fluid. In one embodiment, the nebulizer is spill-proof when the nebulizer is being carried.
A nebulizer in accordance with the present disclosure has several advantages over conventional nebulizers, including portability, ease of use, universal recharging, and quiet and efficient delivery of medication. Preferably, the nebulizer in accordance with the present disclosure can be carried in a shirt or pants pocket. In one embodiment, the nebulizer is portable and spill-proof when a reservoir of the nebulizer is filled with a fluid. In one embodiment, the nebulizer is spill-proof when the nebulizer is being carried.
In one embodiment, the nebulizer in accordance with the present disclosure is free of a hose. In one embodiment, the nebulizer in accordance with the present disclosure is free of a mask. In one embodiment, the nebulizer in accordance with the present disclosure is free of a separate compressor unit.
The nebulizer in accordance with the present disclosure is easy to use. It can be loaded by simply pouring or dripping a standard packaged amount of fluid into the reservoir. In certain embodiments, the reservoir is replenishable with a second fluid. Alternatively, a pre-filled, disposable reservoir can be inserted into the nebulizer. Conventional piezoelectric nebulizers and ultrasonic nebulizers do not use pre-filled, disposable reservoirs. Compared with conventional piezoelectric nebulizers and ultrasonic nebulizers, the nebulizer of the present invention is easier to operate because a user may simply insert a pre-filled, disposable reservoir into the nebulizer. Also, the nebulizer can be operated with a single on-off switch. In certain embodiments, the nebulizer has a self-contained mouthpiece that may be flipped open without requiring additional tubes or masks. In preferred embodiments, the mouthpiece remains attached to the nebulizer and does not protrude from the nebulizer body while being carried. Also, the reservoir and mouthpiece can be removed for easy cleaning.
In one embodiment, the nebulizer may have a universal recharging feature achieved with a lithium ion battery that may be recharged using a USB port on the nebulizer. In a preferred embodiment, the battery may be recharged while the battery remains inside the nebulizer, i.e., without being removed from the nebulizer.
In preferred embodiments, the nebulizer in accordance with the present disclosure provides an aerosol with approximately 70% or more of its particles in the range considered to be respirable, described by those skilled in the art as Respirable Particle Fraction. This allows deep and efficient delivery of medication.
The dimensions and weight of the nebulizer in accordance with the present disclosure are such that it can be easily carried or moved to another location. In one embodiment, the nebulizer can be carried in a shirt or pants pocket. In one embodiment, the nebulizer is about 11.9 cm×5.4 cm×2.7 cm. In one embodiment, the total length of the nebulizer is no greater than about 20 cm. In one embodiment, the nebulizer's weight is about 98.5 g including the battery.
The housing 20 may comprise two molded pieces, a front cover 1 and a back cover 5, which pieces may snap together and provide a watertight seal. In one embodiment, no screws or adhesives are used. In another embodiment, at least one screw is used to hold together the front cover 1 and the back cover 5. The front cover 1 has a cavity 13 for holding the mouthpiece 30 (
The mouthpiece 30 may comprise a top part 2 and a bottom part 3 (
The mouthpiece 30 collects the aerosol or vapor produced by the nebulizer and delivers it to the user's mouth. The mouthpiece 30 may have at least one aperture 31 to facilitate efficient filling of the mouthpiece. For example, the mouthpiece 30 may have an aperture 31 close to one end of the mouthpiece 30 (
The reservoir 40 holds a fluid that is turned into an aerosol or vapor by the nebulizer and delivered to the user. The fluid may contain a pharmaceutically active ingredient. The reservoir 40 may comprise a front part 6 and a back part 7 (
Preferably, the internal volume of the reservoir is 3 ml-6 ml. More preferably, the internal volume of the reservoir is 5 ml.
The reservoir 40 may be made of materials that are nontoxic and inert to the fluid contained in the reservoir. For example, it may be made of polycarbonate resin. Preferably, it is made of LEXAN polycarbonate resin.
The reservoir 40 may be filled with a package containing a predetermined amount of the fluid. In one embodiment, the package may contain a single unit dose of pharmaceutical active ingredient. Alternatively, the reservoir 40 may be disposable and allow another pre-packaged reservoir to be inserted into the nebulizer. In one embodiment, a reservoir plug/stopper 10 is integrated into the hinged lid 8 for ease of use (
The disk 50 has multiple pores at its center. In certain embodiments, the disk has about 1,000 to 2,800 pores, preferably about 1,000-1,200, depending on the material used for the disk. The disk may be made of any suitable materials. For example, the disk may be made of stainless steel, preferably medical grade stainless steel. In another embodiment, the disk is made of an alloy of nickel (Ni) and cobalt (Co). The size of the pores may range from about 4 to 5 microns. In certain embodiments, the pores are round or substantially round, and the size of the pores means the diameter of the pores. The disc 50 may be sandwiched between an outflow port of the reservoir 40 and an exit port in the front cover 1 of the housing 20. The nebulizer may comprise a component 4 surrounding the disk (
The disk 50 is caused to vibrate at a high frequency in the direction of the fluid only, increasing the pressure on that side of the disk, creating a pressure differential that causes the fluid to move through the disk to create an aerosol for delivery. The disk may vibrate at a frequency ranging from 100 kilohertz (kHz) to 200 kHz. Preferably, the disk vibrates at a frequency of about 110 kHz. The amplitude of the vibration may be AC 80 v. In certain embodiments, the resultant aerosol has a particle or droplet size considered by those skilled in the art to be a respirable particle dose. In certain embodiments, the disk vibrates creating a pressure differential that forces the fluid through 4 to 5 micron holes that aerosolize the fluid into respirable droplets. The vibration of the disk 50 creates an aerosol or vapor that is fed into the mouthpiece 30 for inhalation. This process is different from conventional ultrasonic nebulizers that fire ultrasonic waves at the fluid to vaporize the surface of the fluid.
The nebulizer may comprise a power source for providing energy for operating the nebulizer. For example, the power source may be a battery 71, such as a lithium ion battery or other rechargeable batteries. Preferably, the battery is a lithium ion battery. In one embodiment, the battery may be recharged while the battery remains inside the nebulizer, i.e., without being removed from the nebulizer. In one embodiment, the battery allows at least 60 minutes of use. The battery may be rechargeable. Preferably, the battery may be charged through a USB port, which may be covered by a plug 11 (
In certain embodiments, the unit that is configured to cause the disk 50 to vibrate may comprise a PCB 61 (
In one embodiment, the nebulizer may further comprise a timer. The nebulizer may contain a control unit that is configured to give a time-limited treatment. This feature allows a patient to adjust the amount of the fluid that is nebulized and delivered. For example, a patient may take the full amount of a single dose of the fluid contained in the reservoir 40 by keeping the nebulizer on for a certain period of time or take a fraction (e.g., one-third) of the single dose of the fluid contained in the reservoir 40 by keeping the nebulizer on for a corresponding fraction (e.g., one-third) of said period of time. As such, the fluid in the reservoir 40 may comprise a single dose of a pharmaceutically active ingredient or multiple fractional doses of the active ingredient. A patient using the nebulizer may titrate the dose based on time.
The fluid contained in the reservoir 40 may be an aqueous solution, suspension, mixture, or formulation containing a solvent or free of a solvent. In certain embodiments, the fluid may comprise a pharmaceutically active ingredient. The active ingredients that may be used include albuterol, albuterol and ipratropium, arformoterol tartrate, budesonide, colistimethate, cromolyn sodium, dexamethasone, dornase alpha, fluticasone, formoterol, ipratropium bromide, levalbuterol, mometasone and formoterol, and tobramycin.
While various embodiments have been described, other embodiments are plausible. It should be understood that the foregoing descriptions of various examples of nebulizers are not intended to be limiting, and any number of modifications, combinations, and alternatives of the examples may be employed.
The embodiments described herein are merely illustrative, as numerous other embodiments may be implemented without departing from the spirit and scope of the present invention. Moreover, while certain features of the invention may be described above only in the context of certain examples or configurations, these features may be exchanged, added, and removed from and between the various embodiments or configurations while remaining within the scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 14/990,338 filed 2016 Jan. 7, which claims priority to U.S. Patent Application No. 62/101,193 filed 2015 Jan. 8, both of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62101193 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14990338 | Jan 2016 | US |
Child | 16906390 | US |